01 1Boehringer Ingelheim (Canada) Ltd.
02 3Boehringer lngelheim Animal Health Canada Inc.
03 8Gowling WLG (Canada) LLP
01 12326048
02 12414063
03 22795030
04 42906666
05 42946281
01 8BUPIVACAINE | MELOXICAM
02 2MELOXICAM
03 2Meloxicam
01 1Oral supension
02 8SOLUTION (EXTENDED RELEASE)
03 1Solution for injection
04 2TABLET (CHEWABLE)
01 12019-03-23
02 12021-06-19
03 22031-04-27
04 42034-03-13
05 42035-04-20
Patent Expiration Date : 2021-06-19
Date Granted : 2008-06-17
Brand Name : METACAM
Patent Number : 2414063
Filing Date : 2001-06-19
Strength per Unit : 20 mg / mL
Dosage Form : Solution for injection
Human Or VET : Veterinary
Route of Administration : Intravenous, Subcutaneous
Patent Expiration Date : 2021-06-19
Date Granted : 2008-06-17
Patent Expiration Date : 2019-03-23
Date Granted : 2008-08-12
Brand Name : METACAM
Patent Number : 2326048
Filing Date : 1999-03-23
Strength per Unit : 0.5 mg/mL
Dosage Form : Oral supension
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2019-03-23
Date Granted : 2008-08-12
Patent Expiration Date : 2031-04-27
Date Granted : 2019-04-09
Brand Name : METACAM
Patent Number : 2795030
Filing Date : 2011-04-27
Strength per Unit : 1 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2031-04-27
Date Granted : 2019-04-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-04-27
Date Granted : 2019-04-09
Brand Name : METACAM
Patent Number : 2795030
Filing Date : 2011-04-27
Strength per Unit : 2.5 mg
Dosage Form : TABLET (CHEWABLE)
Human Or VET : Veterinary
Route of Administration : ORAL
Patent Expiration Date : 2031-04-27
Date Granted : 2019-04-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 60 mg / 2.3 mL / 1.8 mg / 2.3 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 60 mg / 2.3 mL / 1.8 mg / 2.3 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 200 mg / 7 mL / 6 mg / 7 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 200 mg / 7 mL / 6 mg / 7 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Brand Name : ZYNRELEF
Patent Number : 2946281
Filing Date : 2015-04-20
Strength per Unit : 300 mg / 10.5 mL / 9 mg / 10.5 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2035-04-20
Date Granted : 2022-12-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Brand Name : ZYNRELEF
Patent Number : 2906666
Filing Date : 2014-03-13
Strength per Unit : 300 mg / 10.5 mL / 9 mg / 10.5 mL
Dosage Form : SOLUTION (EXTENDED RELEASE)
Human Or VET : Human
Route of Administration : INSTILLATION
Patent Expiration Date : 2034-03-13
Date Granted : 2019-12-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
